Showing results (231-240 of 560) with videos related to
Sort By:
Pageof 56
Neurology International|September 26, 2025
Association Between Carotid Artery Small Plaque on Computed Tomography Angiography and Embolic Stroke of Undetermined SourceJunpei Nagasawa, Tatsuhiro Yokoyama, Makiko Ogawa, et al.Videogie : an Official Video Journal of the American Society for Gastrointestinal Endoscopy|July 29, 2024
Transjejunal fine-needle biopsy using a forward-viewing echoendoscope for diagnosis of a rare hereditary paragangliomaKazuma Saito, Masanori Kobayashi, Minato Yokoyama, et al.Chemical Senses|February 11, 2005
Measurements of several metallic elements and matrix metalloproteinases (MMPs) in saliva from patients with taste disorderMamoru Watanabe, Masumi Asatsuma, Akihiro Ikui, et al.Journal of Gastroenterology and Hepatology|June 26, 2020
Relation of geriatric nutritional risk index with clinical risks in elderly-onset ulcerative colitisMasaaki Higashiyama, Shunsuke Komoto, Yasuo Suzuki, et al.Hepato-Gastroenterology|May 15, 2012
Time trend and risk factors for reoperation in Crohn's disease in JapanToshiaki Watanabe, Iwao Sasaki, Akira Sugita, et al.Journal of Gastroenterology|March 3, 2012
Effects of family history on inflammatory bowel disease characteristics in Japanese patientsErika Kuwahara, Keiko Asakura, Yuji Nishiwaki, et al.Inflammatory Intestinal Diseases|December 1, 2025
An Early Phase 2 Double-Blind, Placebo-Controlled Study of E6011, a Novel Anti-Fractalkine Antibody, in Patients with Crohn's DiseaseTaku Kobayashi, Toshifumi Hibi, Mamoru Watanabe, et al.Intestinal Research|December 10, 2019
Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trialsToshifumi Hibi, Makoto Naganuma, Eisei Oda, et al.Surgical Endoscopy|May 23, 2022
Feasibility, efficacy, and cautionary note of endoscopic resection for gastric tube cancer after esophagectomyYasuhiro Inokuchi, Mamoru Watanabe, Kei Hayashi, et al.Inflammatory Bowel Diseases|March 8, 2011
Interval of less than 5 years between the first and second operation is a risk factor for a third operation for Crohn's diseaseToshiaki Watanabe, Iwao Sasaki, Akira Sugita, et al.Pageof 56